Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP331155.RABlm4moimfSoz4KcwIhU1rN-SZvaio0eoRsTkCT7ZzqM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP331155.RABlm4moimfSoz4KcwIhU1rN-SZvaio0eoRsTkCT7ZzqM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP331155.RABlm4moimfSoz4KcwIhU1rN-SZvaio0eoRsTkCT7ZzqM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP331155.RABlm4moimfSoz4KcwIhU1rN-SZvaio0eoRsTkCT7ZzqM130_provenance.
- NP331155.RABlm4moimfSoz4KcwIhU1rN-SZvaio0eoRsTkCT7ZzqM130_assertion description "[Bioassay studies indicate that these low levels of soluble CD95 in the CSF of some patients with malignant glioma cells are unlikely to interfere with CD95-based immunotherapy of malignant gliomas in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331155.RABlm4moimfSoz4KcwIhU1rN-SZvaio0eoRsTkCT7ZzqM130_provenance.
- NP331155.RABlm4moimfSoz4KcwIhU1rN-SZvaio0eoRsTkCT7ZzqM130_assertion evidence source_evidence_literature NP331155.RABlm4moimfSoz4KcwIhU1rN-SZvaio0eoRsTkCT7ZzqM130_provenance.
- NP331155.RABlm4moimfSoz4KcwIhU1rN-SZvaio0eoRsTkCT7ZzqM130_assertion SIO_000772 10066095 NP331155.RABlm4moimfSoz4KcwIhU1rN-SZvaio0eoRsTkCT7ZzqM130_provenance.
- NP331155.RABlm4moimfSoz4KcwIhU1rN-SZvaio0eoRsTkCT7ZzqM130_assertion wasDerivedFrom befree-20150227 NP331155.RABlm4moimfSoz4KcwIhU1rN-SZvaio0eoRsTkCT7ZzqM130_provenance.
- NP331155.RABlm4moimfSoz4KcwIhU1rN-SZvaio0eoRsTkCT7ZzqM130_assertion wasGeneratedBy ECO_0000203 NP331155.RABlm4moimfSoz4KcwIhU1rN-SZvaio0eoRsTkCT7ZzqM130_provenance.
- befree-20150227 importedOn "2015-02-27" NP331155.RABlm4moimfSoz4KcwIhU1rN-SZvaio0eoRsTkCT7ZzqM130_provenance.